Informing patients about tardive dyskinesia

Arch Gen Psychiatry. 1985 Sep;42(9):866-71. doi: 10.1001/archpsyc.1985.01790320034005.

Abstract

The effects of a formal (written) approach v an informal (oral) approach to obtaining informed consent for neuroleptic treatment were compared in 25 schizophrenic outpatients with tardive dyskinesia. Both groups had significant increases in knowledge, but only the informal/oral presentation group retained significant new knowledge at two-month follow-up. Overall, patients did not learn the information deemed most relevant for rational decision making about neuroleptic treatment. Younger patients started out with more knowledge and retained significant new knowledge at follow-up. All study patients remained in treatment and all but one remained on neuroleptic regimens. There was no increase in relapse or treatment noncompliance in the study population compared with a comparison group. While information about tardive dyskinesia can be safely disclosed to schizophrenic outpatients, such disclosure is evidently most meaningful when repeated informally in the context of a therapeutic relationship.

MeSH terms

  • Adult
  • Age Factors
  • Ambulatory Care
  • Antipsychotic Agents / adverse effects*
  • Attitude to Health
  • Decision Making
  • Dyskinesia, Drug-Induced / etiology*
  • Female
  • Follow-Up Studies
  • Hospitalization
  • Hospitals, State
  • Humans
  • Informed Consent* / legislation & jurisprudence
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care
  • Patient Compliance
  • Risk
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents